In ovarian cancer, IL-6 increases thrombopoietin expression by hepatocytes, which increases platelet production by megakaryocytes (reviewed in [25]) providing an additional link between inflammation and platelet-dependent thrombin generation. Here, IL6 is linked to ovarian cancer.